LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.

    Hu, Yanmei / Ma, Chunlong / Szeto, Tommy / Hurst, Brett / Tarbet, Bart / Wang, Jun

    ACS infectious diseases

    2021  Volume 7, Issue 3, Page(s) 586–597

    Abstract: As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four SARS-CoV-2 main protease ( ... ...

    Abstract As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four SARS-CoV-2 main protease (M
    MeSH term(s) Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/pharmacology ; Alanine/analogs & derivatives ; Alanine/pharmacology ; Animals ; Antiviral Agents/pharmacology ; Caco-2 Cells ; Carbonates/pharmacology ; Cathepsin L/antagonists & inhibitors ; Cell Line ; Chlorocebus aethiops ; Coronavirus 229E, Human/drug effects ; Coronavirus 3C Proteases/antagonists & inhibitors ; Coronavirus NL63, Human/drug effects ; Coronavirus OC43, Human/drug effects ; Drug Combinations ; Glycoproteins/pharmacology ; HEK293 Cells ; Humans ; Leucine/pharmacology ; Middle East Respiratory Syndrome Coronavirus/drug effects ; Oligopeptides/pharmacology ; Proline/analogs & derivatives ; Proline/pharmacology ; SARS-CoV-2/drug effects ; Serine Endopeptidases/metabolism ; Sulfonic Acids/pharmacology ; Vero Cells ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; Carbonates ; Drug Combinations ; Glycoproteins ; Oligopeptides ; Sulfonic Acids ; calpain inhibitors ; calpain inhibitor 2 (110115-07-6) ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (89BT58KELH) ; Proline (9DLQ4CIU6V) ; Serine Endopeptidases (EC 3.4.21.-) ; transmembrane serine protease 2, human (EC 3.4.21.-) ; Cathepsin L (EC 3.4.22.15) ; Coronavirus 3C Proteases (EC 3.4.22.28) ; Leucine (GMW67QNF9C) ; GC376 (H1NMJ5XDG5) ; Alanine (OF5P57N2ZX)
    Language English
    Publishing date 2021-03-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2373-8227
    ISSN (online) 2373-8227
    DOI 10.1021/acsinfecdis.0c00761
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture.

    Hu, Yanmei / Ma, Chunlong / Szeto, Tommy / Hurst, Brett / Tarbet, Bart / Wang, Jun

    bioRxiv : the preprint server for biology

    2020  

    Abstract: As the COVID-19 pandemic continues to fold out, the morbidity and mortality are increasing daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain ... ...

    Abstract As the COVID-19 pandemic continues to fold out, the morbidity and mortality are increasing daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain inhibitors II and XII and GC-376 with potent antiviral activity against infectious SARS-CoV-2 in cell culture. Despite the weaker enzymatic inhibition of calpain inhibitors II and XII against Mpro compared to GC-376, calpain inhibitors II and XII had more potent cellular antiviral activity. This observation promoted us to hypothesize that the cellular antiviral activity of calpain inhibitors II and XII might also involve the inhibition of cathepsin L in addition to Mpro. To test this hypothesis, we tested calpain inhibitors II and XII in the SARS-CoV-2 pseudovirus neutralization assay in Vero E6 cells and found that both compounds significantly decreased pseudoviral particle entry into cells, indicating their role in inhibiting cathepsin L. The involvement of cathepsin L was further confirmed in the drug time-of-addition experiment. In addition, we found that these four compounds not only inhibit SARS-CoV-2, but also SARS-CoV, MERS-CoV, as well as human coronaviruses (CoVs) 229E, OC43, and NL63. The mechanism of action is through targeting the viral Mpro, which was supported by the thermal shift binding assay and enzymatic FRET assay. We further showed that these four compounds have additive antiviral effect when combined with remdesivir. Altogether, these results suggest that boceprevir, calpain inhibitors II and XII, and GC-376 are not only promising antiviral drug candidates against existing human coronaviruses, but also might work against future emerging CoVs.
    Keywords covid19
    Language English
    Publishing date 2020-11-01
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2020.10.30.362335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir.

    Xia, Zilei / Sacco, Michael / Hu, Yanmei / Ma, Chunlong / Meng, Xiangzhi / Zhang, Fushun / Szeto, Tommy / Xiang, Yan / Chen, Yu / Wang, Jun

    ACS pharmacology & translational science

    2021  Volume 4, Issue 4, Page(s) 1408–1421

    Abstract: SARS-CoV-2 main protease ( ... ...

    Abstract SARS-CoV-2 main protease (M
    Language English
    Publishing date 2021-06-09
    Publishing country United States
    Document type Journal Article
    ISSN 2575-9108
    ISSN (online) 2575-9108
    DOI 10.1021/acsptsci.1c00099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

    Ma, Chunlong / Hurst, Brett / Hu, Yanmei / Szeto, Tommy / Tarbet, Bart / Wang, Jun

    bioRxiv

    Abstract: A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is ... ...

    Abstract A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is highly contagious and has an overall mortality rate of 6.4% as of April 15, 2020. There is no vaccine or antiviral available for SARS-CoV-2. In this study, we report our discovery of inhibitors targeting the SARS-CoV-2 main protease (Mpro). Using the FRET-based enzymatic assay, several inhibitors including boceprevir, GC-376, calpain inhibitors II, XII, and MG-132 were identified to have potent activity with single-digit to submicromolar IC50 values in the enzymatic assay. The mechanism of action of the hits was further characterized using enzyme kinetic studies and thermal shift binding assays. Significantly, four compounds (boceprevir, GC-376, calpain inhibitors II and XII) inhibit SARS-CoV-2 viral replication in cell culture with EC50 values ranging from 0.49 to 3.37 micromolar. Notably, boceprevir, calpain inhibitors II and XII represent novel chemotypes that are distinct from known Mpro inhibitors. Overall, the compounds identified herein provide promising starting points for the further development of SARS-CoV-2 therapeutics.
    Keywords covid19
    Language English
    Publishing date 2020-04-20
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2020.04.20.051581
    Database COVID19

    Kategorien

  5. Article ; Online: Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture

    Hu, Yanmei / Ma, Chunlong / Szeto, Tommy / Hurst, Brett / Tarbet, Bart / Wang, Jun

    bioRxiv

    Abstract: As the COVID-19 pandemic continues to fold out, the morbidity and mortality are increasing daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain ... ...

    Abstract As the COVID-19 pandemic continues to fold out, the morbidity and mortality are increasing daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain inhibitors II and XII and GC-376 with potent antiviral activity against infectious SARS-CoV-2 in cell culture. Despite the weaker enzymatic inhibition of calpain inhibitors II and XII against Mpro compared to GC-376, calpain inhibitors II and XII had more potent cellular antiviral activity. This observation promoted us to hypothesize that the cellular antiviral activity of calpain inhibitors II and XII might also involve the inhibition of cathepsin L in addition to Mpro. To test this hypothesis, we tested calpain inhibitors II and XII in the SARS-CoV-2 pseudovirus neutralization assay in Vero E6 cells and found that both compounds significantly decreased pseudoviral particle entry into cells, indicating their role in inhibiting cathepsin L. The involvement of cathepsin L was further confirmed in the drug time-of-addition experiment. In addition, we found that these four compounds not only inhibit SARS-CoV-2, but also SARS-CoV, MERS-CoV, as well as human coronaviruses (CoVs) 229E, OC43, and NL63. The mechanism of action is through targeting the viral Mpro, which was supported by the thermal shift binding assay and enzymatic FRET assay. We further showed that these four compounds have additive antiviral effect when combined with remdesivir. Altogether, these results suggest that boceprevir, calpain inhibitors II and XII, and GC-376 are not only promising antiviral drug candidates against existing human coronaviruses, but also might work against future emerging CoVs.
    Keywords covid19
    Language English
    Publishing date 2020-11-01
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2020.10.30.362335
    Database COVID19

    Kategorien

  6. Article: Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay.

    Xia, Zilei / Sacco, Michael Dominic / Ma, Chunlong / Townsend, Julia Alma / Kitamura, Naoya / Hu, Yanmei / Ba, Mandy / Szeto, Tommy / Zhang, Xiujun / Meng, Xiangzhi / Zhang, Fushun / Xiang, Yan / Marty, Michael Thomas / Chen, Yu / Wang, Jun

    bioRxiv : the preprint server for biology

    2021  

    Abstract: The papain-like protease ( ... ...

    Abstract The papain-like protease (PL
    Language English
    Publishing date 2021-03-16
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2021.03.15.435551
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.

    Ma, Chunlong / Sacco, Michael D / Hurst, Brett / Townsend, Julia A / Hu, Yanmei / Szeto, Tommy / Zhang, Xiujun / Tarbet, Bart / Marty, Michael T / Chen, Yu / Wang, Jun

    bioRxiv : the preprint server for biology

    2020  

    Abstract: A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is ... ...

    Abstract A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is highly contagious and has an overall mortality rate of 6.96% as of May 4, 2020. There is no vaccine or antiviral available for SARS-CoV-2. In this study, we report our discovery of inhibitors targeting the SARS-CoV-2 main protease (M
    Keywords covid19
    Language English
    Publishing date 2020-01-06
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2020.04.20.051581
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.

    Ma, Chunlong / Sacco, Michael Dominic / Hurst, Brett / Townsend, Julia Alma / Hu, Yanmei / Szeto, Tommy / Zhang, Xiujun / Tarbet, Bart / Marty, Michael Thomas / Chen, Yu / Wang, Jun

    Cell research

    2020  Volume 30, Issue 8, Page(s) 678–692

    Abstract: A new coronavirus SARS-CoV-2, also called novel coronavirus 2019 (2019-nCoV), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is ... ...

    Abstract A new coronavirus SARS-CoV-2, also called novel coronavirus 2019 (2019-nCoV), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is highly contagious and has an overall mortality rate of 6.35% as of May 26, 2020. There is no vaccine or antiviral available for SARS-CoV-2. In this study, we report our discovery of inhibitors targeting the SARS-CoV-2 main protease (M
    MeSH term(s) A549 Cells ; Animals ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Betacoronavirus/enzymology ; COVID-19 ; Caco-2 Cells ; Chlorocebus aethiops ; Coronavirus 3C Proteases ; Coronavirus Infections/metabolism ; Coronavirus Infections/virology ; Cysteine Endopeptidases/chemistry ; Cysteine Endopeptidases/metabolism ; Drug Discovery/methods ; Glycoproteins/pharmacology ; Humans ; Inhibitory Concentration 50 ; Kinetics ; Pandemics ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/virology ; Proline/analogs & derivatives ; Proline/pharmacology ; Protein Conformation ; Pyrrolidines/chemistry ; Pyrrolidines/pharmacology ; SARS-CoV-2 ; Sulfonic Acids ; Vero Cells ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Nonstructural Proteins/chemistry ; Viral Nonstructural Proteins/metabolism ; Virus Replication/drug effects
    Chemical Substances Antiviral Agents ; Glycoproteins ; Pyrrolidines ; Sulfonic Acids ; Viral Nonstructural Proteins ; calpain inhibitors ; N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (89BT58KELH) ; Proline (9DLQ4CIU6V) ; Cysteine Endopeptidases (EC 3.4.22.-) ; Coronavirus 3C Proteases (EC 3.4.22.28) ; GC376 (H1NMJ5XDG5)
    Keywords covid19
    Language English
    Publishing date 2020-06-15
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1319303-x
    ISSN 1748-7838 ; 1001-0602
    ISSN (online) 1748-7838
    ISSN 1001-0602
    DOI 10.1038/s41422-020-0356-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.

    Ma, Chunlong / Sacco, Michael Dominic / Xia, Zilei / Lambrinidis, George / Townsend, Julia Alma / Hu, Yanmei / Meng, Xiangzhi / Szeto, Tommy / Ba, Mandy / Zhang, Xiujun / Gongora, Maura / Zhang, Fushun / Marty, Michael Thomas / Xiang, Yan / Kolocouris, Antonios / Chen, Yu / Wang, Jun

    ACS central science

    2021  Volume 7, Issue 7, Page(s) 1245–1260

    Abstract: The papain-like protease ( ... ...

    Abstract The papain-like protease (PL
    Language English
    Publishing date 2021-06-18
    Publishing country United States
    Document type Journal Article
    ISSN 2374-7943
    ISSN 2374-7943
    DOI 10.1021/acscentsci.1c00519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors.

    Kitamura, Naoya / Sacco, Michael Dominic / Ma, Chunlong / Hu, Yanmei / Townsend, Julia Alma / Meng, Xiangzhi / Zhang, Fushun / Zhang, Xiujun / Ba, Mandy / Szeto, Tommy / Kukuljac, Adis / Marty, Michael Thomas / Schultz, David / Cherry, Sara / Xiang, Yan / Chen, Yu / Wang, Jun

    Journal of medicinal chemistry

    2021  Volume 65, Issue 4, Page(s) 2848–2865

    Abstract: The main protease ( ... ...

    Abstract The main protease (M
    MeSH term(s) Animals ; Antiviral Agents/chemical synthesis ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; COVID-19/metabolism ; Chlorocebus aethiops ; Coronavirus 3C Proteases/antagonists & inhibitors ; Coronavirus 3C Proteases/isolation & purification ; Coronavirus 3C Proteases/metabolism ; Cysteine Proteinase Inhibitors/chemical synthesis ; Cysteine Proteinase Inhibitors/chemistry ; Cysteine Proteinase Inhibitors/pharmacology ; Dose-Response Relationship, Drug ; Drug Design ; Humans ; Microbial Sensitivity Tests ; Models, Molecular ; Molecular Structure ; Proline/analogs & derivatives ; Proline/chemical synthesis ; Proline/chemistry ; Proline/pharmacology ; Pyrrolidines/chemical synthesis ; Pyrrolidines/chemistry ; Pyrrolidines/pharmacology ; SARS-CoV-2/drug effects ; SARS-CoV-2/enzymology ; Sulfonic Acids/chemical synthesis ; Sulfonic Acids/chemistry ; Sulfonic Acids/pharmacology ; Vero Cells ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; Cysteine Proteinase Inhibitors ; Pyrrolidines ; Sulfonic Acids ; N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (89BT58KELH) ; Proline (9DLQ4CIU6V) ; 3C-like proteinase, SARS-CoV-2 (EC 3.4.22.-) ; Coronavirus 3C Proteases (EC 3.4.22.28) ; GC376 (H1NMJ5XDG5)
    Language English
    Publishing date 2021-04-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c00509
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top